Biography

Born in Havana, Cuba, Dr. Vispo is an Cuban biotechnologist who got his Laurea in Biology at Havana University one of the most traditional universities in Cuba. He obtained his PhD in Biology in 1997 after a combined research performed at the Biology Dept of the Torvergata University in Rome (Italy) and the Center for Genetic Engineering and Biotechnology in Havana Cuba.
Nelson had several postdoctoral positions at the Paul-Ehrlich-Institut, Langen, and Cosmix Molecular Biologicals GmbH, Braunschweig, Germany, and also in Torvergata University. He has several awards and honors from the Academy of Sciences from Cuba. He also has an important fellowship from the Alexander Von Humboldt Foundation.
Nelson is a molecular biology with over 28 years of experience in phage display technology, immunology, cancer, molecular biology and clinical trials. He also has an extensive experience in teaching undergraduate and graduate level courses at university level. In addition, Dr. Vispo is a current scientific editor of several magazines including Revista Bionatura a new peer review Ecuadorian magazine in the field of  biotechnology.
 Dr. Santiago Vispo arrived to Ecuador in 2014 as a consultant in biotechnology for the Industry Ministry with a Prometeo scholarship from SENECYST and began his professorship at Yachay Tech University.

Summary of Interests
Molecular Biology. Biotechnology and Phage Display
Clinical Trials


Selected Publications
Combinatoria Molecular. N. Santiago Vispo (book) Elfos Scientiae. 2004
Identification and characterization of phage-displayed peptide mimetics of Neisseria meningitidis serogroup B capsular polysaccharide. Menéndez T, Santiago-Vispo NF, Cruz-Leal Y, Coizeau E, Garay H, Reyes O, Batista Y, Cobas K, Carmenate T, Chinea G, Guillén G. Int J Med Microbiol. 2011;301(1):16-25. Epub 2010 Aug 14.
Preferential selection of Cys-constrained peptides from a random phage-displayed library by anti-glucitollysine antibodies. Rojas G, Pupo A, Del Rosario Aleman M, Vispo NS. J Pept Sci. 2008;14(11):1216-21.
Antitumor effect of a novel proapoptotic peptide that impairs the phosphorylation by the protein kinase 2 (casein kinase 2). Perea SE, Reyes O, Puchades Y, Mendoza O, Vispo NS, Torrens I, Santos A, Silva R, Acevedo B, López E, Falcón V, Alonso DF. Cancer Res. 2004;64(19):7127-9.
Characterization of epitopes on human interleukin-2 using phage displayed-peptide libraries: insights into antibody-peptide interactions. Vispo NS, Araña MJ, Chinea G, Ojalvo AG, Cesareni G. Hybridoma. 1999;18(3):251-5.
Displaying human interleukin-2 on the surface of bacteriophage. Vispo NS, Callejo M, Ojalvo AG, Santos A, Chinea G, Gavilondo JV, Araña MJ. Immunotechnology. 1997;3(3):185-93.